Butorphanol Tartrate Spray, Metered
Product Images NDC 0054-3090

10 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 0054-3090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem.jpg (Chem)

Chem.jpg (Chem)
Chemical structure of Butorphanol Tartrate, showing the molecular arrangement of the active ingredient with its characteristic cycloalkane and phenol groups, along with the tartrate moiety.*
FDA Label Image

Graph1.jpg (Image 01)

Graph1.jpg (Image 01)
Graph depicting plasma concentration (ng/mL) over time (hours) comparing intravenous (IV), nasal spray (NS), and intramuscular (IM) administration of a drug. The curves show the concentration decline for each route up to 12 hours post-administration, with sample sizes noted for each group.*
FDA Label Image

Figure-01 (Image 02)

Figure-01 (Image 02)
An instructional illustration showing a person holding a tissue against their nose, depicting nasal hygiene or blowing the nose, which is relevant to the nasal spray administration route of Butorphanol Tartrate spray.*
FDA Label Image

Figure-02 (Image 03)

Figure-02 (Image 03)
Butorphanol Tartrate Nasal Spray USP, 10 mg per mL, metered spray dosage form for nasal use only. The label includes storage instructions at 20° to 25°C (68° to 77°F) and notes that the product is for prescription use only. It is distributed by West-Ward Pharmaceuticals Corp., Eatontown, NJ.*
FDA Label Image

Figure-03 (Image 04)

Figure-03 (Image 04)
An instructional illustration showing a hand holding a nasal spray bottle with a finger pressing down on the pump to release a spray mist. An arrow indicates the downward pressing action on the spray pump.*
FDA Label Image

Figure-04 (Image 05)

Figure-04 (Image 05)
An instructional black and white line drawing showing a person administering a nasal spray. The illustration depicts the person holding the spray bottle with one hand and inserting the nozzle into one nostril, demonstrating the proper technique for using a metered nasal spray device.*
FDA Label Image

Figure-05 (Image 06)

Figure-05 (Image 06)
An instructional illustration showing a person using a nasal spray. The person holds the spray bottle with one hand and inserts the spray tip into one nostril while holding the other nostril closed with their other hand, demonstrating proper administration technique.*
FDA Label Image

Figure-06 (Image 07)

Figure-06 (Image 07)
A line illustration showing a person administering a nasal spray using a metered dose spray device, with the nozzle placed into one nostril and the spray bottle held in the hand.*
FDA Label Image

Figure-07 (Image 08)

Figure-07 (Image 08)
An instructional line drawing showing a side profile of a person’s face, focusing on the nose and mouth area, likely demonstrating the proper use or positioning for nasal administration of a spray.*
FDA Label Image

Bottle Label Image (Image 09)

Bottle Label Image (Image 09)
Butorphanol Tartrate 10 mg per mL nasal spray, metered dose, in a 2.5 mL container. The label states it is for nasal use only and is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label includes storage instructions and dosage notice referencing the package insert, with NDC 0054-3090-36.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.